Erasca (ERAS) Free Cash Flow (2020 - 2026)
Erasca (ERAS) posted Free Cash Flow of -$27.4 million for Q1 2026, down 26.24% on a QoQ basis from -$21.7 million in Q4 2025, and up 13.34% year-over-year from -$24.2 million in Q1 2025.
Erasca (ERAS) Free Cash Flow (2020 - 2026) Analysis & Trends
Erasca's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$27.4 million for Q1 2026.
- Quarterly Free Cash Flow rose 13.34% year-over-year to -$27.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$91.4 million (up 15.26% YoY) and the FY2025 annual result came in at -$95.6 million, up 12.69% from the prior year.
- Free Cash Flow was -$27.4 million for Q1 2026 at Erasca, down from -$21.7 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$20.6 million in Q2 2025 and bottomed at -$33.3 million in Q1 2024.
- A 5-year average of -$26.7 million and a median of -$26.2 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 109.92% — and 2025, when it rose 29.58%.
- Erasca's Free Cash Flow stood at -$27.2 million in 2022, then grew by 8.69% to -$24.9 million in 2023, then increased by 1.23% to -$24.6 million in 2024, then grew by 11.58% to -$21.7 million in 2025, then decreased by 26.24% to -$27.4 million in 2026.
- Business Quant data shows ERAS's Free Cash Flow at -$27.4 million in Q1 2026, -$21.7 million in Q4 2025, and -$21.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - | -27.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.42 Mn |
| Mar 31, 2026 | -27.42 Mn |
| Dec 31, 2025 | -21.72 Mn |
| Dec 31, 2025 | -21.72 Mn |
| Sep 30, 2025 | -21.66 Mn |
| Sep 30, 2025 | -21.66 Mn |
| Jun 30, 2025 | -20.56 Mn |
| Jun 30, 2025 | -20.56 Mn |
| Mar 31, 2025 | -31.64 Mn |
| Mar 31, 2025 | -31.64 Mn |
| Dec 31, 2024 | -24.56 Mn |
| Dec 31, 2024 | -24.56 Mn |
| Sep 30, 2024 | -22.42 Mn |
| Sep 30, 2024 | -22.42 Mn |
| Jun 30, 2024 | -29.20 Mn |
| Jun 30, 2024 | -29.20 Mn |
| Mar 31, 2024 | -33.29 Mn |
| Mar 31, 2024 | -33.29 Mn |
| Dec 31, 2023 | -24.87 Mn |
| Dec 31, 2023 | -24.87 Mn |